Litigation (Details) € in Thousands, $ in Millions |
1 Months Ended | |||
|---|---|---|---|---|
|
Sep. 30, 2025
USD ($)
|
Jun. 30, 2022
EUR (€)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2020
USD ($)
|
|
| IMRALDI Patent Litigation | ||||
| Loss Contingencies [Line Items] | ||||
| Loss contingency, damages sought, value | € | € 13,450 | |||
| Convergence | ||||
| Loss Contingencies [Line Items] | ||||
| Loss contingency, estimate of possible loss | $ 49.9 | $ 200.0 | ||
| Genentech | ||||
| Loss Contingencies [Line Items] | ||||
| Loss contingency, damages sought, value | $ 88.3 | |||
| Litigation Settlement Interest | $ 35.9 | |||
| X | ||||||||||
- Definition Interest expense (income) directly attributable to an award in settlement of litigation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Reflects the estimated amount of loss from the specified contingency as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|